JOHNSON AND JOHNSON

1. JOHNSON AND JOHNSON By : Siraj Haq

2. Johnson and Johnson Presentation includes: Company history Corporate structure Management structure Employee relations policies Financial analysis Stock history State of industry, and Competition analysis. Current issue to be addressed: • The current issue of product recalls is addressed in this presentation, along with discussing possible solutions in solving this problem.

3. COMPANY HISTORY • Founded in 1886 • Johnson & Johnson (JNJ) was founded by the Johnson brothers , in New Brunswick, NJ. • From left to right, Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson

4. COMPANY HISTORY • “Modern Methods of Antiseptic Wound Treatment” was published in 1988 • served as the guide in antiseptic surgery field

5. COMPANY HISTORY • In year 1894 • Maternity kitswere launched to make childbirth safer. • In the same year, the company introduced baby powder to the market, which began the company’s movement into baby products.

6. COMPANY HISTORY • In year 1932 • Robert Wood Johnson II, son of the original founder, took over the company • Served as the chairman until 1963. • Robert Jr. was a WWII Army General. • Believed in decentralization • Under his management, the managers were given substantial freedom, and company believed and stuck to this way in conducting business to this day

7. COMPANY HISTORY

8. COMPANY HISTORY Between 1989 and 2006 JNJ acquired • Neutrogena Corporation • Kodak’s Clinical Diagnostics • Cordis Corporation • Tibotec-Virco BVBA • Centocorand • Pfizer Consumer Healthcare

9. Company history

10. COMPANY HISTORY - present Today the Johnson and Johnson Family of Companies ranks as: • The world’s sixth-largest consumer health company • The world’s largest and most diverse medical devices and diagnostics company • The world’s fifth-largest biologics company, and • The world’s eighth-largest pharmaceuticals company JNJ employs over 180,000 people across the United States. Worldwide, Johnson & Johnson is made up of over 275 companies located across 60 countries.

11. Company profile

12. Consumer products The consumer products are available to the general public for purchase and can be found in grocery stores, drug stores, and other retail outlets. The first component of the consumer segment is baby products, which consist of popular lines like Johnson’s ® Destin ® and Prim’age ®

13. Consumer products The consumer segment also consists of cosmetic care product lines like Neutrogena ® Aveeno® Clean & Clear ® Bebe ® Roco® Rogaine ® Lubriderm ® Visine ® and Acuvue®

14. Consumer products also includes wound care and topicals, Oral Healthcare products, Womens products and Eye products. Examples of a few include big brands like • Band-Aid ® Bengay ® Neosporin ® Listerine ® Rembrandt ® K-Y ® Carefree® Tylenol ® Zyrtec ® Benadryl®Splenda® and Lactaid ®

15. Medical Devices & Diagnostics Orthopedic products include implants, joint replacements, and sports medicine products. Lifesaving medical surgery products include cardiovascular disease products, coronary disease products, peripheral vascular and obstructive disease products (stents), and neurovascular surgery products.

16. Medical Devices & Diagnostics Diagnostic tools include products for arrhythmias and diabetes, blood glucose monitors, and insulin delivery devices. Surgical room products include general surgery products, bariatric surgery tools, urologic surgery tools, hernia surgery tools, aesthetics products, surgical instruments, and infection prevention products

17. Pharmaceutical Products JNJ invested $5.1 billion in 2011 for research in new drugs. The company focuses on a vast variety of therapeutic areas including cardiovascular, internal Medicine, immunology, central nervous system, infectious diseases, and oncology. The company also has a robust pipeline of popular products like Aciphex® Remicaide ® Risperdal ® Duragesic®Procrit ® and Topamax®

18. Company structure

19. The Board of Directors

20. THE SIX COMMITTEES The Consumer, Pharmaceutical, and Medical Devices & Diagnostic Segments are then each managed individually and usually regionally

21. Employee relations policies • Employees are the company’s greatest asset. • Treating their employees well is one of their top priorities, because it is the employees who help the company progress and flourish. • The company does not tolerate discrimination on the basis of gender, age, race, nationality, sexual orientation, physical ability, and thinking styles.

22. Employee relations policies Diversity University In order to educate employees about the value of diversity Employees are required to complete training modules that demonstrate diversity and the company’s commitment. The Office of Diversity & Inclusion for employees who may have any concerns

23. Employee relations policies Employees Resource Group Voluntary, employee-led group based on similar interests and goals. Allows for a forum for employees to pass ideas off of and further develop professionally. The company also supports Mentoring Programs that pair employees with mentors, to further develop both professionally and personally. • one of the top 50 companies for Latinas, and • one of the top 100 companies for working mothers for the past 26 consecutive years

24. Financial analysis TOTAL REVENUE NET INCOME Source : Hoover’s Online database http://eres.medaille.edu:2292/H/company360/overview.html

25. Financial analysis • The price per ratios compare how well the company is related to the price of its shares. • Having a high return on assets and on equity shows that the company’s management is utilizing its resources properly and efficiently. • The current ratio, measures the liquidity and ability to pay off debts, and since anything over 1 is a good sign, JNJ is doing very well. Source : Hoover’s Online database http://eres.medaille.edu:2292/H/company360/overview.html

26. Stock history • The current stock price for the company is $85.22. This demonstrates Johnson & Johnson’s ability to grow, since the stock was valued at $65.17 in March of 2012 and $50 in January of 2009. • JNJ pays a dividend of $2.44 for its 2,795,320 outstanding shares, and not many companies are able to accomplish these stats in today’s economic down times Source : Hoover’s Online database http://eres.medaille.edu:2292/H/company360/overview.html

27. Stock history • Stock prices of Johnson and Johnson, over past 10 years (04-12) Source : Hoover’s Online database http://eres.medaille.edu:2292/H/company360/overview.html

28. State of industry – consumer products • Companies in this industry manufacture cosmetics, grooming products, and toiletries. • The demand for personal care products is expected to grow at a constant rate since the demand to look good is constant.

29. State of industry – consumer products • The aging population may help the company further grow as more money is spent on cosmetics and anti-aging products. • Hoovers Financial forecasted that this industry will grow at a compounded rate of 4 percent between 2013 and 2017

30. State of industry – Pharmaceutical products • Companies that develop, manufacture, and market pharmaceutical drugs. • Currently, the demand for pharmaceuticals are on the rise with a rise in cancer, HIV/AIDs, and other rare diseases. • Hoovers Financial forecasted the industry will grow at a compounded rate of 5 percent between 2013 and 2017

31. State of industry – Medical devices and diagnostics • Manufacture surgical and medical equipment, dental equipment, and surgical appliances. • New technology helps ensure that medical procedures are safer, more accurate, and easier in many cases. • The industry is expected to grow as new technology is developed. The industry is forecasted to grow at a compounded rate of 5 percent between 2013 and 2017.

32. competition analysis 2012 Annual Sales and Net profit margins of JNJ and its biggest competitors. TOTAL REVENUE NET profit margins Source : Hoover’s Online database http://eres.medaille.edu:2292/H/company360/overview.html

33. “recalls” Current issue to be Addressed

34. The issue of recalls • JNJ has been under the spotlight for numerous product recalls that pose a safety threat to its patients and consumers. • JNJ needs to make the necessary adjustments, as the numerous product recalls and associated lawsuits has put the company in an unfavorable position as well has cost the company and its investors billions of Dollars.

35. ‘Due care’ theory “Ethics of care” the company is prompt to recall products to ensure consumer and patient safety. Although there is little guarantee of all defective products being pulled off shelves, and the message is conveyed to all product users. “Due Care Theory” As the manufacturer and being trusted/depended on by the consumers, it’s the duty of JNJ to take care that consumers are not harmed by JNJs product.

36. What is a recall??

37. Recalls – An industry wide problem

38. The Depuy ASR Hip implant recall • As a result of the complications, failure rates, and recall, the company now faces over 10,000 lawsuits with regards to the DePuy hip replacement. • In a recent hearing, the company lost its first DePuY ASR lawsuit. The company is responsible for paying the plaintiff $8.3 million in damages. • With estimated over 30,000 patients transplanted with this device, JNJ might suffer a loss totaling in billions.

39. Negligence ?? It is believed that the company was aware of the poor design of the product - the metal cup and ball components that would rub against each other, resulting in metallic debris in the surrounding tissue. The metallic debris could lead to tissue and bone damage.

40. Proposed changes ?

41. Proposed changes

42. “Root Cause Analysis”

43. Future of Johnson and johsnon?? $

44. References • Causey, M. (2013, February 11). Study: FDA enforcement growing for medical device companies. AssurX Blog. Retrieved April 27, 2013, from http://blog.assurx.com/2013/02/11/study-fda-enforcement-growing-for-medical-device-companies/ • Demian, H. (n.d.). Preventing and addressing problems in the medical device recalls. Retrieved April 8, 2013, from http://www.fda.gov/MedicalDevices/Safety/RecallsCorrectionsRemovals/default.htm • Hoovers Online Database (2013a). Competitive landscape. Retrieved April 9, 2013, from http://eres.medaille.edu:2292/H/company360/competitiveLandscape.html • Hoovers Online Database (2013b). History overview. Retrieved April 9, 2013, from http://eres.medaille.edu:2292/H/company360/history.html • Hoovers Online Database (2013c). Industry overview. Retrieved April 9, 2013, from http://eres.medaille.edu:2292/H/industry360/overview.html?industryId=1192 • Hoovers Online Database (2013d). Stock quote and chart. Retrieved April 9, 2013, from • http://eres.medaille.edu:2292/H/company360/detailedStockQuote.html • Johnson & Johnson (2013a). Board of directors. Retrieved April 7, 2013, from http://www.investor.jnj.com/governance/board.cfm • Johnson & Johnson (2013b). Company structure. Retrieved April 7, 2013, from http://www.jnj.com/connect/about-jnj/company-structure/ • Johnson & Johnson (2013c). Our company. Retrieved April 7, 2013, from www.jnj.com/connect/about-jnj/ • Johnson & Johnson (2013d). Our history timeline. Retrieved April 7, 2013, from http://www.jnj.com/connect/about-jnj/company-history/ • Johnson & Johnson (2013e). Our people and diversity. Retrieved April 7, 2013, from http://www.jnj.com/connect/about-jnj/diversity/ • Lawson, A. (2013, March 19). DePuy hip lawsuits, Johnson & Johnson loses ASR lawsuit. Injury Lawyer News. Retrieved April 7, 2013, from http://injurylawyer-news.com/2013/03/johnson-johnson-loses-first-depuy-asr-lawsuit/ • Silverman, E. (2013, April 5). A real false alarm: Johnson & Johnson recalls another product | Pharmalive. Pharmalive | The Pulse of the Pharmaceutical Industry. Retrieved April 9, 2013, from http://www.pharmalive.com/real-false-alarm-johnson-johnson-recalls-another-product

45. QUESTIONS ??? QUESTIONS ???